ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO1013

Endoplasmic Reticulum (ER) and Mitochondrial Stress Markers of Heavy Metals Exposure in the CRIC Study

Session Information

Category: CKD (Non-Dialysis)

  • 2303 CKD (Non-Dialysis): Mechanisms

Authors

  • Baca, Justin T., University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
  • Taylor, Robert M., University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
  • Pankratz, V. Shane, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
  • Yang, Wei, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Wang, Xue, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Unruh, Mark L., University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
  • Shah, Vallabh O., University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
Background

Chronic kidney disease (CKD) is a progressive disease that affects ~13% of the population. Heavy metal (HM) exposure contributes to the rapid progression of kidney disease due to persistent stress stimuli that lead to dysregulation of inflammatory and oxidative stress pathways. Our hypothesis is that cumulative exposure to metals increases progression of CKD via inflammation and oxidative stress.

Methods

We obtained matching nail samples (n=40) from 20 participants of the Chronic Renal Insufficiency Cohort (CRIC) at baseline (n=20) and 24-month follow-up (n=20). An equal number of subjects had fast progressing disease (n=10) and stable disease (n=10). Samples were a random pick of all available samples and were sent anonymized prior to analysis. We quantified twenty-five metalloids in the nail samples using Inductively Coupled Plasma Mass Spectrometry (ICP/MS). Mercury was measured on a Flow Injector Mercury System (FIMS), and boron with ICP/Optical Emission Spectroscopy (ICP/OES). Biochemical markers were measured at the CRIC Scientific and Data Coordinating Center (SDCC) using commercial kits.

Results

Marker concentrations at baseline and follow-up are shown for the fast progressing and stable progression cohorts.

Conclusion

Although not significant, in the fast-progressing disease cohort, ATF, VAR6, and PERK were all increased while GRP78, Caspase 12, and mitofilin were all decreased at follow-up. In the stable cohort, all markers were increased at follow-up with the exceptions of mitofilin (decreased) and PERK (unchanged). Increased ER and mitochondrial stress markers showed a trend towards higher metal burden.

Funding

  • NIDDK Support